Seeking Alpha

CRIS
  Curis, Inc. - NASDAQ

8/21/2014, 8:25 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CRIS vs. ETF Alternatives
Company Description
Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Sector: Healthcare
Industry: Biotechnology
Country: United States